Thyroidectomy

Treatment for Thyroid Cancer

Effectiveness
95%
Safety Score
65%
Clinical Trials
195
Participants
1M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate (tumor removal)
Treatment Duration
Single procedure
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,000
Side Effect Mgmt:$300
Total Annual:$1,300
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$11,921/QALY
QALYs Gained
4
Comparison vs Active Surveillance (for Papillary Thyroid Microcarcinoma)
Cost Difference
+$5,000/year
More expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Thyroidectomy Outcomes

for Thyroid Cancer

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+90%
Remission Rate
+85%
Common Side Effects
Temporary hypoparathyroidism/hypocalcemia
+15%
Permanent hypoparathyroidism/hypocalcemia
+2%
Temporary recurrent laryngeal nerve injury/hoarseness
+7%
Permanent recurrent laryngeal nerve injury/hoarseness
+1%
Bleeding/hematoma
+2%
Infection
+0.5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
4 active trials recruiting for Thyroidectomy in Thyroid Cancer

Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer

NCT06958601NOT YET RECRUITING
View Study
400 participants
OBSERVATIONAL
Started: May 1, 2025

This Study is Mainly About Finding Incidence Among Other Factors of Thyroid Cancer in Patient with Benign Disease As MNG to Early Discover of the Malignancy to Save the Patient from Aggressive Procedure

NCT06730971NOT YET RECRUITING
View Study
300 participants
OBSERVATIONAL
Started: Dec 1, 2024

Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)

NCT05412680RECRUITINGNA
View Study
60 participants
INTERVENTIONAL
São Paulo, Brazil
Started: May 25, 2022

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

NCT05604963RECRUITINGNA
View Study
456 participants
INTERVENTIONAL
Crewe, United Kingdom +34 more
Started: Feb 14, 2022
Completed Clinical Trials
8 completed trials for Thyroidectomy in Thyroid Cancer

Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer

NCT05178186COMPLETEDNA
View Study
23K participants
INTERVENTIONAL
Cagliari, Italy
Started: Jun 20, 2022

Red Blood Cell Distributions (RDW, RDW-CW) and Lymphocyte Monocyte Ratios (LMR) for the Malignant Thyroid Nodules

NCT06283368COMPLETED
View Study
172 participants
OBSERVATIONAL
Started: Jan 1, 2016

Compare the Aesthetic Effect of Different Thyroidectomies

NCT03239769COMPLETEDNA
View Study
120 participants
INTERVENTIONAL
Started: Jun 1, 2012

Effect of Dexmedetomidine After Thyroidectomy

NCT02412150COMPLETEDNA
View Study
139 participants
INTERVENTIONAL
Gwangju, South Korea
Started: Apr 1, 2014

Khon Kaen University's Thyroidectomy Registry

NCT03031639COMPLETED
View Study
98 participants
OBSERVATIONAL
Muang, Thailand
Started: Jan 13, 2017

Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola

NCT05760690COMPLETEDNA
View Study
160 participants
INTERVENTIONAL
Guangzhou, China
Started: Jan 1, 2015

The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience

NCT04500925COMPLETED
View Study
301 participants
OBSERVATIONAL
Started: Jan 1, 2006

Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma

NCT05263141COMPLETEDNA
View Study
80 participants
INTERVENTIONAL
Guangzhou, China
Started: Mar 1, 2022
Showing 20 of 197 total trials